Note: Ingredients listed on restricted chemical lists
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
General Information
Revision date
2019-10-03
Product name
Wakix (pitolisant) 4.45 mg and 17.8 mg Tablets
Product Synonyms
• Ciproxidine; Pitolisant Hydrochloride; Tiprolisant
1.2.1 Relevant identified uses
Pharmaceutical for human use in treatment of excessive daytime sleepiness in adult patients with narcolepsy
1.2.2. Uses advised against
Any use not directed by prescribing physician
Manufacturer Name
Harmony Biosciences, LLC
Icons in SDS
Company Information
company name
Harmony Biosciences, LLC
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
OSHA HCS 2012 United States (US) According to: OSHA 29 CFR 1910.1200 HCS
2.1 Classification of the substance or mixture
OSHA HCS 2012 • Skin Irritation 2 Eye Irritation 2 Effects on or via Lactation
2.2 Label elements
OSHA HCS 2012 WARNING
Hazard statements
Causes skin irritation Causes serious eye irritation
Prevention
Obtain special instructions before use Do not breathe dust. Avoid direct contact during pregnancy/while nursing. Wash thoroughly after handling. Do not eat, drink or smoke when handling this product. Wear protective gloves/protective clothing/eye protection/face protection.
Response
If on skin Wash with plenty of water Take off contaminated clothing and wash before reuse. Specific treatment, see supplemental first aid information. If skin irritation occurs: Get medical advice/attention. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. IF exposed or concerned: Get medical advice/attention.
2.3 Other hazards
OSHA HCS 2012 • Under United States Regulations (29 CFR 1910.1200 - Hazard Communication Standard), this product is considered hazardous.
